More on ELDN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eledon Pharmaceuticals (NQ:ELDN)
Delayed: 3.92 +0.22 (5.95%)
Prev. Close $3.70  
Open$3.78 
52 Wk High$ 
52 Wk Low$ 
Day High$3.96 
Day Low$3.75 
P/E N/A  
EPS$ 
Volume2,640,354 

Friends, Peers and Foes (?): NCEL, PSH, PSH.DE, SEOVF SVA (more...)

Jun 8, 2026 07:02 AM Eledon reports insulin independence in all 12 type 1 diabetes patients
Jun 8, 2026 07:00 AM Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
Jun 4, 2026 04:31 PM Eledon to present islet transplant trial data at diabetes conference
Jun 4, 2026 04:31 PM Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific
May 20, 2026 04:05 PM Eledon Pharmaceuticals to present kidney transplant study data at congress
May 20, 2026 04:05 PM Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
May 15, 2026 04:13 PM Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: BIOTECHNOLOGY VALUE FUND L P
May 13, 2026 05:12 PM Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c
May 13, 2026 04:21 PM Form 10-Q Eledon Pharmaceuticals, For: Mar 31
May 13, 2026 04:15 PM Form 8-K Eledon Pharmaceuticals, For: May 13
View All Articles

Entities mentioned with ELDN

View All Entities